119 related articles for article (PubMed ID: 7787011)
1. Iterative generalized least squares for meta-analysis of survival data at multiple times.
Dear KB
Biometrics; 1994 Dec; 50(4):989-1002. PubMed ID: 7787011
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of summary survival curve data.
Arends LR; Hunink MG; Stijnen T
Stat Med; 2008 Sep; 27(22):4381-96. PubMed ID: 18465839
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia and the position of autologous stem cell transplantation.
Breems DA; Löwenberg B
Semin Hematol; 2007 Oct; 44(4):259-66. PubMed ID: 17961725
[TBL] [Abstract][Full Text] [Related]
4. Practical methodology of meta-analysis of individual patient data using a survival outcome.
Katsahian S; Latouche A; Mary JY; Chevret S; Porcher R
Contemp Clin Trials; 2008 Mar; 29(2):220-30. PubMed ID: 17884735
[TBL] [Abstract][Full Text] [Related]
5. [Bone marrow transplantation in the treatment of acute leukemias].
Moiseev SI; Ganapiev AA; Abdulkadyrov KM
Ter Arkh; 1996; 68(12):8-10. PubMed ID: 9054052
[TBL] [Abstract][Full Text] [Related]
6. [Current situation and perspective for treatment of acute myelogenous leukemia in adults].
Fukushima T; Ueda T
Gan To Kagaku Ryoho; 1998 Feb; 25(3):295-302. PubMed ID: 9492819
[TBL] [Abstract][Full Text] [Related]
7. A regression survival model for testing the proportional hazards hypothesis.
Quantin C; Moreau T; Asselain B; Maccario J; Lellouch J
Biometrics; 1996 Sep; 52(3):874-85. PubMed ID: 8924576
[TBL] [Abstract][Full Text] [Related]
8. Multiple-outcome meta-analysis of clinical trials.
Berkey CS; Anderson JJ; Hoaglin DC
Stat Med; 1996 Mar; 15(5):537-57. PubMed ID: 8668877
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of pairs of survival curves under heterogeneity: a Poisson correlated gamma-frailty approach.
Fiocco M; Putter H; van Houwelingen JC
Stat Med; 2009 Dec; 28(30):3782-97. PubMed ID: 19899066
[TBL] [Abstract][Full Text] [Related]
10. Autologous bone marrow transplantation for leukemia.
Stuart RK
Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
[TBL] [Abstract][Full Text] [Related]
11. A general framework for random effects survival analysis in the Cox proportional hazards setting.
Sargent DJ
Biometrics; 1998 Dec; 54(4):1486-97. PubMed ID: 9883547
[TBL] [Abstract][Full Text] [Related]
12. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
[TBL] [Abstract][Full Text] [Related]
14. Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials.
Wahed AS; Tsiatis AA
Biometrics; 2004 Mar; 60(1):124-33. PubMed ID: 15032782
[TBL] [Abstract][Full Text] [Related]
15. Long-term survivor model with bivariate random effects: applications to bone marrow transplant and carcinoma study data.
Lai X; Yau KK
Stat Med; 2008 Nov; 27(27):5692-708. PubMed ID: 18712761
[TBL] [Abstract][Full Text] [Related]
16. Response in acute myeloid leukemia.
Estey E
Clin Adv Hematol Oncol; 2008 Feb; 6(2):113-7. PubMed ID: 18347562
[TBL] [Abstract][Full Text] [Related]
17. Dynamic comparison of Kaplan-Meier proportions: monitoring a randomized clinical trial with a long-term binary endpoint.
Brittain E; Follmann D; Yang S
Biometrics; 2008 Mar; 64(1):189-97. PubMed ID: 17680830
[TBL] [Abstract][Full Text] [Related]
18. Random effects survival models gave a better understanding of heterogeneity in individual patient data meta-analyses.
Michiels S; Baujat B; Mahé C; Sargent DJ; Pignon JP
J Clin Epidemiol; 2005 Mar; 58(3):238-45. PubMed ID: 15718112
[TBL] [Abstract][Full Text] [Related]
19. Maximum androgen blockade in advanced prostate cancer: a meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens.
Caubet JF; Tosteson TD; Dong EW; Naylon EM; Whiting GW; Ernstoff MS; Ross SD
Urology; 1997 Jan; 49(1):71-8. PubMed ID: 9000189
[TBL] [Abstract][Full Text] [Related]
20. A joint frailty model for survival and gap times between recurrent events.
Huang X; Liu L
Biometrics; 2007 Jun; 63(2):389-97. PubMed ID: 17688491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
